Primary extranodal diffuse large B‐cell lymphoma: Molecular features, treatment, and prognosis by Si‐Yuan Chen, Meng‐Meng Ji, Peng‐Peng Xu, Wei‐Li Zhao

Get full text

P1164: PEGARSPARGASE AND SINTILIMAB FOR NEWLY DIAGNOSED, ADVANCED STAGE NATURAL KILLER T-CELL LYMPHOMA, NASAL TYPE: AN OPEN-LABEL, SINGLE-ARM, PHASE 2 STUDY. by Jie Xiong, Shu Cheng, LI Wang, Peng-Peng Xu, Wei-LI Zhao

Get full text

P1120: NOVEL TARGETED AGENTS IN COMBINATION WITH R-ICE (R-ICE-X) BASED ON GENOTYPING IN RELAPSED/REFRACTORY DLBCL. by Shen Yige, Yi-Wen Cao, Shu Cheng, Peng-Peng Xu, LI Wang, Wei-LI Zhao

Get full text

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma by Rong Shen, Di Fu, Lei Dong, Mu-Chen Zhang, Qing Shi, Zi-Yang Shi, Shu Cheng, Li Wang, Peng-Peng Xu, Wei-Li Zhao

Get full text

CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis by Chen-xing Zhao, Zi-xun Yan, Jing-jing Wen, Di Fu, Peng-peng Xu, Li Wang, Shu Cheng, Jian-da Hu, Wei-li Zhao

Get full text

Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma by Yu-Jia Huo, Peng-Peng Xu, Li Wang, Hui-Juan Zhong, Di Fu, Qing Shi, Shu Cheng, Shuo Wang, Mu-Chen Zhang, Wei-Li Zhao

Get full text

A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Kil... by Peng-Peng Xu, Jie Xiong, Shu Cheng, Xia Zhao, Chao-Fu Wang, Gang Cai, Hui-Juan Zhong, Heng-Ye Huang, Jia-Yi Chen, Wei-Li Zhao

Get full text

Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma by Ying Fang, Mu-Chen Zhang, Yang He, Chen Li, Hai Fang, Peng-Peng Xu, Shu Cheng, Yan Zhao, Yan Feng, Qian Liu, Li Wang, Wei-Li Zhao

Get full text

B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study by Peng-Peng Xu, Hui-Juan Zhong, Yao-Hui Huang, Xiao-Dong Gao, Xia Zhao, Yang Shen, Shu Cheng, Jin-Yan Huang, Sai-Juan Chen, Li Wang, Wei-Li Zhao

Get full text

MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cells by Zhong Zheng, Peng-Peng Xu, Li Wang, Hui-Jin Zhao, Xiang-Qin Weng, Hui-Juan Zhong, Bin Qu, Jie Xiong, Yan Zhao, Xue-Feng Wang, Anne Janin, Wei-Li Zhao

Get full text

CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis by Yao-Hui Huang, Kun Cai, Peng-Peng Xu, Li Wang, Chuan-Xin Huang, Ying Fang, Shu Cheng, Xiao-Jian Sun, Feng Liu, Jin-Yan Huang, Meng-Meng Ji, Wei-Li Zhao

Get full text

SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential by Jie Xiong, Nan Wang, Hui-Juan Zhong, Bo-Wen Cui, Shu Cheng, Rui Sun, Jia-Yi Chen, Peng-Peng Xu, Gang Cai, Li Wang, Xiao-Jian Sun, Jin-Yan Huang, Wei-Li Zhao

Get full text

Positron emission tomography‐adapted therapy in low‐risk diffuse large B‐cell lymphoma: results of a randomized, phase III, non‐inferiority trial by Qing Shi, Yang He, Hong‐Mei Yi, Rong‐Ji Mu, Xu‐Feng Jiang, Di Fu, Lei Dong, Wei Qin, Peng‐Peng Xu, Shu Cheng, Qi Song, Sai‐Juan Chen, Li Wang, Wei‐Li Zhao

Get full text

JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide by Peng-Peng Xu, Yi-Feng Sun, Ying Fang, Qi Song, Zi-Xun Yan, Yi Chen, Xu-Feng Jiang, Xiao-Chun Fei, Yan Zhao, Christophe Leboeuf, Biao Li, Chao-Fu Wang, Anne Janin, Li Wang, Wei-Li Zhao

Get full text

Integrative genome‐wide chromatin accessibility and transcriptome profiling of diffuse large B‐cell lymphoma by Ying Fang, Mu‐Chen Zhang, Peng‐Peng Xu, Su‐Jiang Zhang, Li Wang, Shu Cheng, Di Fu, Chun‐Kang Chang, Xiao‐Jian Sun, Yan Zhao, Yi‐Jia Tang, Xin Tian, Hong‐Mei Yi, Feng Liu, Wei‐Li Zhao

Get full text

Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphoma by Meng-Ke Liu, Li-Li Cheng, Hong-Mei Yi, Yang He, Xiao Li, Di Fu, Yu-Ting Dai, Hai Fang, Shu Cheng, Peng-Peng Xu, Ying Qian, Yan Feng, Qian Liu, Li Wang, Li Wang, Wei-Li Zhao, Wei-Li Zhao

Get full text

Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma by Jie Xiong, Shu Cheng, Xiao Gao, Shan-He Yu, Yu-Ting Dai, Xin-Yun Huang, Hui-Juan Zhong, Chao-Fu Wang, Hong-Mei Yi, Hao Zhang, Wei-Guo Cao, Rong Li, Wei Tang, Yan Zhao, Peng-Peng Xu, Li Wang, Wei-Li Zhao

Get full text

Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40/OX40L-mediated interaction with Th17 cells by Rui Sun, Pei-Pei Zhang, Xiang-Qin Weng, Xiao-Dong Gao, Chuan-Xin Huang, Li Wang, Xiao-Xia Hu, Peng-Peng Xu, Lin Cheng, Lu Jiang, Di Fu, Bin Qu, Yan Zhao, Yan Feng, Hong-Jing Dou, Zhong Zheng, Wei-Li Zhao

Get full text

Immune Characteristics of Chinese Diffuse Large B-Cell Lymphoma Patients: Implications for Cancer Immunotherapies by Peng-peng Xu, Chun Sun, Xu Cao, Xia Zhao, Hang-jun Dai, Shan Lu, Jian-jun Guo, Shi-jing Fu, Yu-xia Liu, Su-chun Li, Meng Chen, Ron McCord, Jeff Venstrom, Edith Szafer-Glusman, Elizabeth Punnoose, Astrid Kiermaier, Gang Cheng, Wei-li Zhao

Get full text

Clinical and molecular features of Epstein‐Barr virus‐positive diffuse large B‐cell lymphoma: Results in a multi‐center trial by Chen Xing Zhao, Jing Jing Wen, Di Fu, Peng Peng Xu, Shu Cheng, Li Wang, Chao Fu Wang, Xiao Chun Fei, Xin Wang, Jian Feng Zhou, Li Ping Su, Zhuo Wen Chen, Jie Ping Chen, Mei Yun Fang, Ting Liu, Yong Ping Song, Kang Yu, Yan Li, Jian Gu, Ming Hou, Wei Li Zhao, Jian da Hu

Get full text